SCHEMBL6714907

SCHEMBL6714907

COC(=O)C(Cc1ccc(OCCNC(=O)OC(C)(C)C)c(Cl)c1)Oc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.47
PPARD Q03181 2/20 0.47
PPARA Q07869 2/20 0.47
IDO1 P14902 2/20 0.42
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
PTPN1 P18031 4/20 0.40
PTPN22 Q9Y2R2 2/20 0.40
PDK2 Q15119 1/20 0.39
SLC5A1 P13866 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
SUCNR1 Q9BXA5 1/20 0.39
KDM4E B2RXH2 2/20 0.39
POLB P06746 1/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6717857 0.93 PPARG (0.43) PPARGPPARDPPARAIDO1ALDH1A1
SCHEMBL6716377 0.89 IDO1 (0.42) PPARGPPARDPPARAIDO1ALDH1A1
SCHEMBL6717706 0.86 ALDH1A1 (0.43) IDO1ALDH1A1PTPN1PTPN22CA12
SCHEMBL6722536 0.82 IDO1 (0.41) PPARGIDO1ALDH1A1PTPN1PTPN22
SCHEMBL9165272 0.80 IDO1 (0.50) PPARGPPARAIDO1ALDH1A1SMN1; SMN2
SCHEMBL6716355 0.79 ALDH1A1 (0.42) IDO1ALDH1A1KDM4EPOLBHTT
SCHEMBL14804153 0.78 CA12 (0.46) PPARDIDO1ALDH1A1SMN1; SMN2SLC5A1
SCHEMBL6716011 0.77 CA12 (0.50) PPARGPPARASMN1; SMN2PTPN1PTPN22
SCHEMBL28624037 0.76 SMN1; SMN2 (0.47) IDO1SMN1; SMN2CA12CA1CA2
SCHEMBL6715088 0.76 CA12 (0.48) IDO1SMN1; SMN2PDK2SLC5A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 PPARG 23/4885PPARD 200/4885PPARA 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.